Biotech · Private company
Centessa Pharmaceuticals (UK) Limited
Track this companyFree. Adds Centessa Pharmaceuticals (UK) Limited to your Dealase workspace and tells you when its record changes.
Clinical trials65 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- cleminorextonPhase 3 · Narcolepsy Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- LB101Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- ORX750Phase 2 · Narcolepsy Type 1ClinicalTrials.gov · fetched Nov 12, 2026
- ORX142 TabletsPhase 1 · Excessive Daytime SleepinessClinicalTrials.gov · fetched Nov 12, 2026
- ORX489 TabletsPhase 1 · Healthy Adult Male and Female VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of HypersomnolencePHASE2_PHASE3 · RECRUITING · started May 29, 2026ClinicalTrials.gov NCT07598708 · fetched Nov 12, 2026
- A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 YearsPHASE1 · RECRUITING · started Feb 25, 2026ClinicalTrials.gov NCT07413666 · fetched Nov 12, 2026
- A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaPHASE2 · RECRUITING · started Aug 12, 2025ClinicalTrials.gov NCT07096674 · fetched Nov 12, 2026
- A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of AgePHASE1 · RECRUITING · started Jun 30, 2025ClinicalTrials.gov NCT07082829 · fetched Nov 12, 2026
- A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaPHASE2 · RECRUITING · started Dec 23, 2024ClinicalTrials.gov NCT06752668 · fetched Nov 12, 2026
- A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Mar 28, 2023ClinicalTrials.gov NCT05821777 · fetched Nov 12, 2026